Asian Breast Implants Market - Insights

Breast implants are artificial surgery prosthesis made of either silicone gel, silica or saline solutions, which involves reconstruction of breasts to improve the effects of mastectomy or other damages to breasts. This breast implantation procedure is also called as breast augmentation. Breast implant and its reconstruction requires tissue expanders that helps in the expansion of breast muscles and skin. A permanent breast implant is inserted post removal of the tissue expander. Breast implant procedure is performed mostly in an outpatient basis, which takes only an hour or two to finish the implantation process. However, the surgery time can be extended depending on the patient’s condition of breasts, the type of implant to be used, and other factors.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1806

There are few complications and adverse outcomes of breast implants, which could hamper growth of breast implants market. This includes additional surgeries with or without removal of the device, capsular contracture, occurrence of scar tissue around the implant and squeezes the implant, breast pain, changes in nipple and breast sensation, rupture with deflation of saline-filled implants, rupture with or without symptoms (silent rupture) of silicone gel-filled implants.

The Asian Breast Implants market size is estimated to be valued at US$ 140.93 Mn in 2017 and is expected to witness a robust CAGR of 7.0% during the forecast period (2018 - 2026).

Initiatives for assurance of product safety as well as launch of new devices to drive the Asian breast implants market growth

Rapid product developments by manufacturers and their increasing number of approvals by the U.S. FDA are the factors augmenting the growth of the Asian breast implants market. For instance, in June 2017, G&G Biotechnology introduced innovative B-Lite lightweight breast implants. These implants are the first and only lightweight breast implants.

Advancements in technology and improvements in designs, materials, construction, and fill volumes are expected to accelerate the market growth. For instance, in April 2017, Mentor Worldwide LLC received an FDA approval for MemoryGel XTRA silicone gel-filled breast implant that will act as a first tissue breast expander with Dynamic Control Technology to provide precise and controlled expansion. These advancement in technology are expected to provide lucrative opportunity for growth of market in Asia Pacific region.

Increasing prevalence and supportive initiatives by various organizations also aids in growth of the Asian breast Implants market

According to the International Society of Aesthetic Plastic Surgery (ISAPS): 2015 data findings, South Korea and India registered 1,156,234 and 935,487 total cosmetic procedures in 2015, respectively. This statistics states that South Korea ranked third and India ranked fourth among the top ten total cosmetic procedures performed in countries, worldwide in 2015.

Furthermore, different combination of procedures such as reconstruction and cosmetics provided by the surgeons are expected to aid in growth of the market. For instance, breast lift and breast augmentation are two different procedures, which can be combined. Furthermore, silicone gel implant along with fat transfer is also now provided in various hospitals. Such development of new combination treatment is propelling demand for breast implants, which is expected to support growth of emerging economies in Asia.

Click To Continue Reading @ https://www.coherentmarketinsights.com/market-insight/asian-breast-implants-market-1806

For instance, in September 2016, GC Aesthetics Plc introduced the Matrix and the Round Collection breast implant portfolio in South Korea. Also, it made an agreement with CKD BiO Corp. to distribute breast implant in the South Korean market.

Key players operating in the market include Allergen, Inc., Mentor Worldwide LLC, GC Aesthetics Plc, Johnson & Johnson, POLYTECH Health and Aesthetics GmBH, Groupe Sebbin SAS, Arion Laboratories, HansBiomed Co.Ltd. and GG Biotechnology Ltd.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Blog: https://healthcaremarketconsulting.blogspot.com/

This release was published on openPR.